Aim: To characterize the clinical phenotype of type 2 diabetes mellitus (T2DM) with respect to age, gender, and BMI. Method: Anonymized data of 120 183 people with T2DM from the German/Austrian multicenter Diabetes Patienten Verlaufsdokumentation database were analyzed based on chronological age or age at diagnosis (0-19, 20-39, 40-59, 60-79, and R80 years). Age, gender, and BMI comparisons with clinical phenotype were made using c 2 and Kruskal-Wallis tests (SAS V9.2). Results: Of all the patients, 51.3% were male, average age was 67.1G12.7 years, and average disease duration was 9.9G9.1 years. More girls than boys were diagnosed during adolescence and more men than women during adulthood (20-60 years). No gender differences existed when age at diagnosis was R60 years. Patients were obese on average (BMI: 30.5G6.1 kg/m 2 ) and had significantly higher BMI values than German population peers. The BMI gap was widest in the younger age categories and closed with increasing age. Adult women were significantly more obese than men. Obese patients more often had elevated HbA1c (R7.5%), hypertension or dyslipidemia (irrespective of age), microalbuminuria (adults), or retinopathy (elderly) than nonobese patients. More men than women (20-60 years) had hypertension, dyslipidemia, or microalbuminuria while more women than men (R60 years) had hypertension or dyslipidemia. Conclusion: During puberty, more girls than boys were diagnosed with T2DM while during adulthood males predominated. T2DM manifested at comparatively lower BMI in males, and younger patients were more obese at diagnosis. Age, gender, and BMI were also associated with poor metabolic control and cardiovascular disease comorbidities/complications.
Introduction
Type 2 diabetes mellitus (T2DM) is on the rise worldwide and is estimated to affect over 400 million people by 2030 (1) . Obesity is an important risk factor of T2DM and related comorbidities, which has also increased significantly in the last decades and is estimated to affect up to 1 billion people worldwide by 2030 (2) . Early weight gain in childhood and adolescence increases the risk of obesity-related comorbidities and cardiovascular complications in adulthood (3, 4) .
There is established heterogeneity in the determinants of T2DM and in the clinical phenotype. Previous research shows that there are more girls than boys among pediatric patients with T2DM (5, 6) . Among adult patients, this relationship is reversed (7) . Factors that influence this demographic disparity have not been completely clarified. However, understanding the basis of this heterogeneity, and thereby the impact of various risk factors, may open additional avenues for preventing T2DM.
The aim of this study is to investigate how clinical phenotype is related to age, gender, or BMI in a large multicenter group of people with T2DM from pediatric to geriatric age, using data collected under routine conditions in specialized care settings. We additionally aim to investigate the distribution of risk factors for cardiovascular disease (CVD) including hypertension and dyslipidemia, as well as diabetes-related complications such as microalbuminuria and diabetic retinopathy, in the cohort.
Patients and methods
Data were retrieved from the 'Diabetes Patienten Verlaufsdokumentation' (DPV or prospective documentation of diabetes patients) database, a nationwide register for people with diabetes in Germany/Austria. Anonymized, prospectively documented data are transmitted twice a year from participating health care facilities, using the freely available DPV software, to Ulm, Germany, for central analysis. Implausible and inconsistent data are reported back to the centers for verification and correction. DPV data are used for quality assurance/benchmarking and clinical research. This analysis was performed in September 2010 when the DPV database contained diabetes-related data of 225 150 patients with 1 715 282 appointments from 336 participating health facilities. Two hundred and seventy-three centers (hospitals, clinics, diabetesspecialized practices, and general practitioner (GP) offices (primary care)) contributed data from both inand outpatient care for this analysis.
Inclusion criteria were T2DM diagnosis and documented BMI. The diagnosis of T2DM was confirmed by diabetes specialists at DPV centers using German national guidelines that are consistent with World Health Organization/American Diabetes Association (ADA) criteria for diabetes classification (8, 9, 10) . Clinical data were retrieved from patients' records of the last treatment year. Differences in disease duration, HbA1c values, and CVD risk factors were compared between patients of different age, gender, and BMI categories. Data from the Federal Statistical Office of Germany for 2009 (11) and the KIGGS survey (a German, nationwide, representative interview/health examination survey of children and adolescents, 2007) (12) were used for demographic and anthropometric comparisons with adult and pediatric patient data respectively. Obesity was defined as BMI R30 kg/m 2 . Hypertension was defined in adults as use of antihypertensive medication or the median of an individual's blood pressure (BP) measurements during the last treatment year above 140 mmHg (systolic) or above 90 mmHg (diastolic) (13) . Systolic and/or diastolic BP R90th percentile for age, gender, and height or the use of antihypertensive medication was considered as hypertension in pediatric patients. Measurements were standardized according to the guidelines of the German Hypertension League (www.paritaet.org/RR-Liga/). Dyslipidemia was diagnosed where a patient was taking lipid-lowering drugs or had at least one permanently increased measurement of total cholesterol, LDL, and triglycerides (TG) or permanently decreased HDL. Cut-off values were as follows: total cholesterol O5.0 mmol/l, LDL O3.0 mmol/l, HDL !1.0 mmol/l, and TG O1.7 mmol/l (14) . Screening for microalbuminuria was performed using one of the following procedures according to ADA guidelines (10): measurements of the urine albumin:creatinine ratio in random spot samples, or albumin excretion in 24 h or timed overnight samples. Microalbuminuria was diagnosed where at least two urine albumin tests were abnormal. Thresholds were albumin:creatinine ratio of 30-299 mg/mg in spot collections or albumin excretion rate of 30-299 mg/24 h or 20-199 mg/min in timed samples. Local laboratory methods were required to meet German internal and external quality standards (RiliBÄ K) (15) . Diabetic retinopathy was diagnosed where patients had nonproliferative, preproliferative, or proliferative retinopathy including diabetic maculopathy, photocoagulation, advance diabetic eye disease, or blindness. HbA1c values were standardized to the Diabetes Control and Complication Trial Research Group reference range (4.05-6.05%) using multiple of the mean method.
Statistical analysis
Study sample selection and data analysis were conducted with the Statistical Analysis Software (SAS V 9.2, Cary, NC, USA). c 2 statistics and nonparametric group comparisons (Kruskal-Wallis) were conducted. Patients were compared in the following categories: 0-19 years (nZ658), 20-39 years (nZ2730), 40-59 years (nZ27 728), 60-79 years (nZ71 714), and R80 years (nZ17 353). The proportion of males and females with T2DM in different age groups were, respectively, compared with that of sameaged males and females from the German population using c 2 test. Results are reported as percentage or meanGS.D. and 95% confidence interval (CI). P values were adjusted for multiple comparisons according to Holm and P!0.05 was considered significant.
Results

Age
Of all patients, 51.3% (nZ120 183) were male, average current age was 67.1G12.7 years, and average age at diagnosis was 57.2G13.7 years. In the subgroup of patients diagnosed at age 0-19 years, girls outnumbered boys (P!0.001). Conversely, the proportion of men was significantly higher among patients diagnosed between 20 and 59 years (P!0.001). No significant difference was found for gender ratio in patients diagnosed at age R60 years (Fig. 1) . Average disease duration was 9.9G9.1 years and adult women (R20 years) had significantly longer disease duration than men (Table 1) .
With respect to chronological age, girls again outnumbered boys among pediatric patients (63.2%) and among patients aged R80 years (66.9%). When corrected for gender ratio in the general population (11, 12) , a significantly higher proportion of girls was found among pediatric patients only. In all other age categories, the proportion of men was significantly higher. Identical results were found when people with T2DM from Austria (nZ244) were excluded.
Body mass index
On average, study patients were obese (mean BMI: 30.5G6.1 kg/m 2 ). Those in the age category 20-39 years had the highest average BMI (34.3 G7.7 kg/m 2 ). From the age of 40 years onward, BMI decreased significantly with age (Table 1) . With the exception of pediatric patients, women of all age categories had significantly higher BMI values than men of the same age ( Table 2 ). Girls/women and boys/men in all age categories also had significantly higher BMI values than peers in the German population. The BMI increase in people with T2DM was most pronounced in the age groups under 40 years and gradually diminished in higher age categories, remaining, however, statistically significant (Fig. 2) . Comparisons with population data (11, 12) also showed that the risk of T2DM was about fivefold higher in overweight (odds ratio (OR) 4.9; 95% CI: 4.8-5.0) and obese individuals (OR: 5.4; 95% CI: 5.3-5.5) than among normal weight or nonobese persons respectively.
HbA1c
Average HbA1c was 7.6G1.9%. Patients in the age groups 20-39 years (mean: 8.2G2.5%) and 40-59 years (mean: 8.1G2.1%) had the highest HbA1c values (Table 1) . Males aged !60 years had significantly higher HbA1c values than females, while females aged O60 years had significantly higher HbA1c than males ( Table 2 ). The proportion of patients with HbA1c values R7.5% was higher among obese patients than among the nonobese. HbA1c differences between obese and nonobese patients were significant for all female age categories and for males aged R40 years (Table 3) .
Hypertension
On average, 29.6% of patients were diagnosed with hypertension. Among adults, the proportion of hypertension increased up to the category 60-79 years (Table 1) . Under the age of 60 years, hypertension was more common among boys/men and above 60 years among girls/women; gender differences were significant for all age categories (Table 2) . Furthermore, hypertension was significantly more prevalent in obese patients than in the nonobese. This was also true for males and females separately (Table 3) . A significantly higher proportion of men were taking antihypertensive drugs in the age group 20-39 years only. In all other adult age categories, more women than men were taking antihypertensive medication ( Table 2 ). In addition, a significantly higher proportion of obese patients than same-aged nonobese patients (males and females examined separately) was taking antihypertensive drugs. This was true for all age categories except men aged R80 years (Table 3) .
Dyslipidemia
Elevated cholesterol, LDL or TG, or reduced HDL affected 74.8% of patients in this study. Mostly affected were patients in the age categories 20-39 and 40-59 years. Men in the group 20-39 years more frequently had dyslipidemia than women (86.8 vs 78.8%; P!0.001). Significant differences were also found among patients aged R60 years, with more dyslipidemia in women (Table 2 ). In addition, for all age categories, dyslipidemia was significantly more prevalent among obese boys/ men and girls/women than among nonobese patients of the same sex (Table 3 ). More men than women aged R20 years were taking lipid-lowering drugs (Table 2) , and obese patients in all age categories (males and females examined separately) were more frequently taking lipid-lowering drugs than nonobese patients. These differences were significant for men and women aged R20 years (Table 3 ).
Microalbuminuria
The proportion of patients diagnosed with microalbuminuria (sample average: 37.6%) increased significantly up to the age group 60-79 years (Table 1) . In all age groups R20 years, more men than women had microalbuminuria. In addition, the proportion of microalbuminuria among obese women was significantly higher than among nonobese women in all adult age categories. This was also true for obese men aged 40-79 years, as opposed to nonobese men of the same age ( Table 2 ). Figure 1 Cross-sectional analysis of male:female ratio among diabetes patients in different age categories, showing female predominance in the pediatric-onset group and male predominance in adults up to 59 years. No gender differences were found after the age of 60 years. The male:female ratio of the German population (11, 12) was used for correcting the effect of longer life expectancy in females.
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Chol, total cholesterol; TG, triglycerides.
Retinopathy
On average, retinopathy affected 14.5% of patients and the proportion diagnosed with either preproliferative or proliferative retinopathy increased significantly with age up to the category 60-79 years (Table 1) . Women aged R60 years more often had diabetic retinopathy than men, but the gender difference was only significant for the age group R80 years (16.5 vs 14.2%; PZ0.03).
Additionally, the proportion of retinopathy among obese women (R40 years) was significantly higher than among same-aged nonobese women (Table 3 ). In the case of men, a significantly higher proportion of retinopathy was found among the obese compared with the nonobese in the age group 60-79 years only (14.4 vs 17.0%; P!0.001).
Discussion
In this cross-sectional analysis, we describe demographic and anthropometric characteristics of 120 183 people with T2DM and examine age, gender, and BMI associations using standardized multicenter data, collected under real-life conditions, compared with German population data. Similar to other studies (5, 6), female predominance was found among patients diagnosed during the pediatric age. This may be the result of hormonal changes during puberty that aggravate insulin resistance in females (16) . Conversely, men significantly outnumbered women among patients diagnosed at 20-59 years of age. The proportion of men with T2DM also significantly exceeded that of healthy males in the German population. Adult men usually have more endocrine active visceral fat that favors insulin resistance, a precursor of metabolic syndrome and diabetes (17, 18) . After the age of 60 years, gender differences in relation to age at diagnosis were no longer present, indicating that risk factors of T2DM were more evenly distributed between men and women ( Fig. 1) . Figure 2 Cross-sectional analysis of BMI, showing that in all age categories, males and females with T2DM have significantly higher BMI values than contemporaries from the German population (11, 12) . The widest difference is seen in the age groups below 40 years. All standard errors are !0.5 kg/m 2 and therefore not visible in the figure.
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People with T2DM in all age categories were on average obese. Compared with peers in the German population, both males and females with T2DM had significantly higher BMI values (Fig. 2) . The BMI gap was widest in the age categories !40 years and narrowed with increasing age, leveling off after the age of 80 years. Other studies have also described similar age-related differences that suggest a stronger contribution of BMI in the onset of T2DM during adolescence and young adulthood than in later years (19, 20) . Comparisons with population data showed a fivefold increase in the risk of T2DM among obese study patients. These results underline the established contribution of BMI in the development of T2DM (21, 22) . Gender differences related to BMI were also found. Adult men (though on average overweight or obese) had significantly lower BMI values than adult women, i.e. T2DM manifested in men at comparatively lower BMI values than in females, indicating male-female BMI risk profile differences. Similar findings have been reported in other studies (23, 24) . In patients older than 80 years, there was a decline in BMI, both in the diabetic group and in the general population, possibly reflecting the influence of malnutrition and frailty.
In the cohort, obesity was also associated with poor metabolic control, hypertension, dyslipidemia, microalbuminuria, and retinopathy. Obese females of all age groups had significantly higher HbA1c values than the nonobese. For males, this was true for patients O40 years only. Males !60 years significantly more often had hypertension and dyslipidemia than sameaged females. Other studies have reported similar findings (25, 26, 27, 28) . Possible reasons for these gender differences include the fact that older women have adverse changes in inflammatory processes and biomarkers (e.g. von Willebrand factor or tissue plasminogen activator) than same-aged men, which favor the development of insulin resistance and exacerbate CVD risk (23, 29) . Furthermore, older women have higher sphingolipid concentrations than men (30) , suggesting increased influences of sphingolipid metabolite concentrations on insulin resistance and subsequent risk of CVD in the face of obesity. However, it is possible that female predominance among patients with dyslipidemia (O60 years) is the result of the fact that a significantly higher proportion of men (O60 years) was taking lipid-lowering drugs (Table 2) . Also, more men than women (20-39 years) were taking antihypertensive medication. This is in line with a study reporting that fewer women than men were treated for modifiable risk factors of T2DM (31) . Nevertheless, in our cohort, more women than men aged O40 years were taking antihypertensive medication.
The proportion of patients with diabetic retinopathy increased with age. Older or obese female patients were more often affected (Tables 2 and 3) . Obesity is associated with diabetic retinopathy in older patients with male-female differences (32, 33, 34) . Nevertheless, the comparatively low prevalence of retinopathy among T2DM patients in this study may in part reflect the positive outcome of the nationwide disease management program for T2DM in Germany, whereby participants significantly more often reported a yearly eye examination by an ophthalmologist than nonparticipants (35, 36) .
In summary, the results of this study are in line with other studies (Table 4) . Study patients (!20 years) are comparable to T2DM patients in the TODAY and SEARCH cohorts (5, 6) with respect to female predominance, high prevalence of obesity, hypertension, and dyslipidemia. Likewise, obesity is more prevalent among T2DM patients than nondiabetic people in the population in our study. A similar finding was reported for adiposity in a UK study including diabetic and nondiabetic people aged 60-79 years, whereby both men and women with T2DM had significantly higher BMI values than nondiabetic contemporaries (23) . Moreover, the widest gap in BMI difference between diabetic and nondiabetic persons was found in the youngest age categories for both genders in our study. This result has also been previously reported (20) as well as the finding that men develop diabetes at comparatively lower BMI values than women (24) . In our study cohort, associations between obesity and poor metabolic control, hypertension, and dyslipidemia were also found. These associations were true for a higher proportion of younger than older patients and more frequently registered among the obese than nonobese. Similar findings have been reported as well (19, 20) . In this regard, there was an age-dependent decline in the proportion of obese patients with poor metabolic control, hypertension, and dyslipidemia in both genders after the age of 40 years in our study, similar to the findings of another report (19) . The associations between obesity and risk of CVD nevertheless remained significant up to the highest age categories (Table 3) . Thus, the originality of our data lies in the fact that associations described elsewhere, with restricted age groups, are studied and expanded across all age categories (from pediatric to geriatric age) allowing for the observation of age-related trends in patients' clinical characteristics. This approach has not been used in any previous comparable study to the best of our knowledge.
Strengths and weaknesses
Even though T2DM has been extensively researched, few studies have used large multicenter data from routine patient care to examine demographic and anthropometric characteristics. This study population is large and homogenous and data collection was systematic and computerized. Different health care settings (specialized diabetes practices, university teaching hospitals, clinics, GP practices, pediatric and adult health care institutions, and in-and outpatient health institutions) located throughout Germany and Austria contributed the data. As such, selection bias is limited but cannot be completely ruled out. Also, to conclusively establish that gender and BMI were responsible for the different associations described with respect to metabolic control and CVD risk, the raw data needs to be adjusted for lifestyle-related confounders like habitual exercise, smoking, drinking, biomarkers, and survival. Furthermore, patients !30 years old are included in the study cohort. A small fraction of these patients may be misclassified as T1DM patients.
Conclusion
This paper provides a descriptive analysis of people with T2DM from Germany and Austria. Phenotypic heterogeneity is present in the cohort. Female gender was associated with disease onset during pediatric age whereas male gender was associated with disease onset in young adulthood. Our results also support studies that demonstrate that obesity contributes more strongly to disease manifestation in young people than in older ones. In addition, we found that diabetes manifested in adult men with BMI values significantly lower than those of adult women, indicating gender-specific risk profiles. Poor metabolic control and comorbidities/ complications of diabetes were also related to gender and BMI. In view of this heterogeneity, diabetes management and prevention strategies should be patient centered (37) .
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